AI-driven cloud analysis platform
iSyncBrain is an AI-driven cloud analysis platform registered as a class II medical device by the Korean FDA.
Source: LinkedIn company description · Retrieved October 13, 2026
iMediSync develops AI-driven platforms focused on early detection for brain health.
The company states a vision of developing early-detection biomarkers for neurological disorders including Parkinson’s disease, TBI, PTSD, ADHD and depression.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The iSyncBrain and iSyncHeart platforms are primarily used by doctors and clinical psychologists for research.
iSyncBrain is an AI-driven cloud analysis platform registered as a class II medical device by the Korean FDA.
Source: LinkedIn company description · Retrieved October 13, 2026
iSyncHeart is an AI cloud-based solution for HRV, registered as a class II medical device by the Korean FDA.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 26, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.